Vincent K. Brooks
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Amentum Faces Mixed Market Reaction After Deal and Analyst Upgrade. Amentum recently secured a preferred supplier role on a $2.8 billion Sellafield nuclear waste deal, which lifted the stock but also triggered a 5.5 % pullback. BNP Paribas upgraded the company to neutral, cutting its price target to $20, while analysts noted the firm’s focus on margin quality over revenue growth. The move comes amid a broader market rally for government‑consulting names, with Amentum’s shares showing a support rejection and a volume spike at the $20 level.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Verisk price targets trimmed as analysts weigh AI impact. BMO Capital and Morgan Stanley recently lowered their price targets for Verisk Analytics to $217 and $215, respectively, while maintaining positive ratings. This adjustment reflects ongoing debate among analysts regarding the company's growth outlook and the potential impact of artificial intelligence on its business model. The stock is currently trading near the upper end of its 52-week range, with an average analyst target of $227.94.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Keybanc cuts Jacobs Solutions price target to $166. Keybanc maintained its Overweight rating on Jacobs Solutions but lowered its price target to $166. This adjustment comes as the stock trades near the top of its 52-week range, with an average analyst target of $162.33. The company also appeared in a list of low-volatility stocks described as risky by one analyst.
Transaction History
| FANG | ▲ Buy | Grant | 982 | $0 | 5/20/2026 | View on chart |
| AMTM | ▲ Buy | Option Exercise | 11,564 | — | 2/6/2026 | View on chart |
| AMTM | ▲ Buy | Grant | 5,062 | $0 | 2/6/2026 | View on chart |
| FANG | ▲ Buy | Grant | 1,417 | $0 | 5/21/2025 | View on chart |
| AMTM | ▲ Buy | Option Exercise | 3,447 | — | 3/5/2025 | View on chart |
| AMTM | ▼ Sell | Other | 6,966 | — | 9/18/2024 | View on chart |
| FANG | ▲ Buy | Grant | 1,035 | $0 | 6/6/2024 | View on chart |
| VRSK | ▲ Buy | Grant | 847 | $0 | 5/15/2024 | View on chart |
| J | ▲ Buy | Grant | 1,401 | $190K | 1/25/2024 | View on chart |
| FANG | ▲ Buy | Grant | 1,527 | $0 | 6/8/2023 | View on chart |
| VRSK | ▲ Buy | Grant | 958 | $0 | 5/17/2023 | View on chart |
| J | ▲ Buy | Grant | 1,559 | $190K | 1/25/2023 | View on chart |
| VRSK | ▲ Buy | Grant | 792 | $0 | 7/1/2022 | View on chart |
| FANG | ▲ Buy | Grant | 1,274 | $0 | 6/9/2022 | View on chart |
| J | ▲ Buy | Grant | 1,512 | $190K | 1/26/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Diamondback Energy Analyst Ratings and Price Targets Updated
Recent analyst actions highlight strong interest in Diamondback Energy, with Scotiabank initiating coverage with an Outperform rating and a $250 price target. RBC Capital reiterated its Outperform stance at $240, while Morgan Stanley maintained Equal-Weight and raised its target to $222. These updates come ahead of the company's upcoming earnings report, reflecting continued sector attention.
Diamondback Energy Analyst Ratings and Price Targets Updated. Recent analyst actions highlight strong interest in Diamondback Energy, with Scotiabank initiating coverage with an Outperform rating and a $250 price target. RBC Capital reiterated its Outperform stance at $240, while Morgan Stanley maintained Equal-Weight and raised its target to $222. These updates come ahead of the company's upcoming earnings report, reflecting continued sector attention.